Cat. No.: HY-172774

TRPV1 antagonist 10

TRPV1 antagonist 10 is an orally active and potent TRPV1 antagonist (IC₅₀ = 33.06 nM), moderate to weak URAT1 (IC₅₀ = 22.51 μM) and GLUT9 (60.25% at 50 μM) inhibitor. TRPV1 antagonist 10 has analgesic and urate-lowering effect. TRPV1 antagonist 10 can be studied for research in hyperuricemia and inflammatory pain.

For research use only. We do not sell to patients.

Purity: 98.54%
CAS No.: 896584-55-7
Formula: C₁₆H₁₄N₂O₅
Molecular Weight:314.29

Storage:

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

TRPV1 antagonist 10 Chemical Structure

CAS No.: 896584-55-7

Size

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- IC₅₀ & Target
- In Vitro
- Parmacokinetics
- In Vivo
Chemical Information
Solvent & Solubility
- In Vitro
Purity & Documentation
References
Help & FAQs
Classifications
Bioz

Biological Activity

Description

IC₅₀ & Target^[1]

TRPV1

36.47 nM (IC₅₀)

TRPV3

>100 μM (IC₅₀)

TRPV4

>100 μM (IC₅₀)

TRPA1

>100 μM (IC₅₀)

TRPM8

6.47 μM (IC₅₀)

CYP1A2

28.31 μM (IC₅₀)

CYP2C9

42.85 μM (IC₅₀)

CYP2C19

9.23 μM (IC₅₀)

CYP2D6

>100 μM (IC₅₀)

CYP3A4M

8.73 μM (IC₅₀)

All TRP Channel Isoforms :

All GLUT Isoforms :

All Cytochrome P450 Isoforms :

All Interleukin Related Isoforms :

All TNF Receptor Isoforms :

In Vitro

TRPV1 antagonist 10 (Compound 39) (50 μM, 24 h) shows 60.25% inhibition rate against GLUT9 in UA (1 mM)-treated HEK293T cells^[1].
TRPV1 antagonist 10 (0-400 μM, 24-72 h) exhibits higher levels of cytotoxicity on HepG2 and HK2 cells with increasing dose and time of incubation^[1].
TRPV1 antagonist 10 (0-100 μM, 3-20 min) shows high metabolic stability in human and rat liver microsomes^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Cytotoxicity Assay^[1]

Cell Line:

HepG2 and HK2 cell lines
Concentration:

0-400 μM
Incubation Time:

24 or 72 h incubation
Result:

Exhibited little cytotoxicity in HepG2 cells after 24 h incubation.
Caused significant cytotoxicity at the concentration of 50 μM after 72 h incubation in HepG2 cells.
Led to significant inhibition of cell viability in HK2 cell line at 200 μM and 24 h incubation.
Had slightly less toxicity in both cell lines in comparison to Benzbromaron (HY-B1135).

Parmacokinetics

Species	Dose	Route	T_1/2	Plasma Concentration	AUC	MRT	Bioavailability	T_max	Clearance (CL)
Rat	1 mg/kg	i.v.	14.38 h	106.16 ng/mL	121.54 ng·h/mL	13.39 h	100 %	/	/
Rat	3 mg/kg	p.o.	8.27 h	37.94 ng/mL	141.01 ng·h/mL	8.78 h	34.4 %	0.5 h	0.018993 mg·h/L

In Vivo

TRPV1 antagonist 10 (Compound 39) (3-20 mg/kg, p.o., one single dose) shows dose-dependent analgesic effect in both Formalin-induced phase I and phase II pain in male Kunming mice model^[1].
TRPV1 antagonist 10 (10-20 mg/kg, p.o., 21 consecutive days) reduces the uric acid level and improves the renal function at 20 mg/kg in hyperuricemia mice model^[1].
TRPV1 antagonist 10 (500 mg/kg, p.o., one single dose) leads to no obvious abnormal behaviors and difference in weight and food intake in healthy Kunming mice^[1].
TRPV1 antagonist 10 (100 mg/kg, p.o., every other day for 14 consecutive days) leads to no obvious abnormal behaviors and difference in weight and food intake in healthy Kunming mice^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Male Kunming mice, 5% Formalin (injected subcutaneously into the right rear toe)-induced persistent pain model (8 weeks, 22-25 g)^[1]
Dosage:

3 mg/kg, 10 mg/kg, 20 mg/kg
Administration:

Oral gavage (p.o.), one single dose
Result:

Showed no obvious anti-nociceptive activity at dose of 3 mg/kg and 10 mg/kg.
Exhibited significantly better analgesic effect with 20 mg/kg dosage in phase I (0-5 min) and phase II (6-45 min) pain.

Animal Model:

Male Kunming hyperuricemia mice model (8 weeks, 22-25 g)^[1]
Dosage:

10 mg/kg, 20 mg/kg
Administration:

Oral gavage (p.o.), 21 consecutive days
Result:

Reduced inflammatory cytokines (IL-1β, TNF-α, and IL-6) with both dosages.
Reduced the level of renal interstitial fibrosis after 21 continuous days.

Chemical Information

CAS No. 896584-55-7
Appearance Solid
Molecular Weight 314.29
Formula C₁₆H₁₄N₂O₅
Color White to off-white
SMILES

O=C(NC1=CC(OCCO2)=C2C=C1)NC3=CC=C(OCO4)C4=C3
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Solvent & Solubility

In Vitro:

DMSO : 70 mg/mL (222.72 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

3.1818 mL

15.9089 mL

31.8177 mL

5 mM

0.6364 mL

3.1818 mL

6.3635 mL

10 mM

0.3182 mL

1.5909 mL

3.1818 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (277 KB)
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Chunxia Liu, et al., Structure Optimization of Natural Product Piperine to Obtain Novel and Potent Analogs with Anti-inflammation Pain and Urate-Lowering Effect, European Journal of Medicinal Chemistry, 2025, 117649, ISSN 0223-5234

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	3.1818 mL	15.9089 mL	31.8177 mL	79.5444 mL
	5 mM	0.6364 mL	3.1818 mL	6.3635 mL	15.9089 mL
	10 mM	0.3182 mL	1.5909 mL	3.1818 mL	7.9544 mL
	15 mM	0.2121 mL	1.0606 mL	2.1212 mL	5.3030 mL
	20 mM	0.1591 mL	0.7954 mL	1.5909 mL	3.9772 mL
	25 mM	0.1273 mL	0.6364 mL	1.2727 mL	3.1818 mL
	30 mM	0.1061 mL	0.5303 mL	1.0606 mL	2.6515 mL
	40 mM	0.0795 mL	0.3977 mL	0.7954 mL	1.9886 mL
	50 mM	0.0636 mL	0.3182 mL	0.6364 mL	1.5909 mL
	60 mM	0.0530 mL	0.2651 mL	0.5303 mL	1.3257 mL
	80 mM	0.0398 mL	0.1989 mL	0.3977 mL	0.9943 mL
	100 mM	0.0318 mL	0.1591 mL	0.3182 mL	0.7954 mL

Keywords

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Product Name:
CAS No.:
Species:
Purity:
Quantity:

TRPV1 antagonist 10

Apoptosis Compound Library

Immunology/Inflammation Compound Library

Membrane Transporter/Ion Channel Compound Library

Metabolism/Protease Compound Library

Neuronal Signaling Compound Library

Anti-Aging Compound Library

Antioxidant Compound Library

Differentiation Inducing Compound Library

Oxygen Sensing Compound Library

Endocrinology Compound Library

Glycolysis Compound Library

Orally Active Compound Library

Glutamine Metabolism Compound Library

Anti-Cancer Metabolism Compound Library

Angiogenesis-Related Compound Library

Mitochondria-Targeted Compound Library

Glucose Metabolism Compound Library

Mechanoreceptors Compound Library

Antidepressant Compound Library

Anti-Prostate Cancer Compound Library

Anti-Pulmonary Fibrosis Compound Library

Pain-Related Compound Library

Mitochondrial Protection Compound Library

Metabolic Enzyme Compound Library

Membrane Protein-targeted Compound Library

Membrane Receptor-targeted Compound Library

Autoimmune Disease Compound Library

Highly Selective Inhibitors Library

Cytokine Inhibitors Library

Ion Channel Compound Library

Multi-Target Compound Library

Radioprotector Library

Bioactive Compound Library Max

MCE Bioactive Compound Library

Bioactive Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

High-Throughput Bioactive Compound Library

Anti-Rheumatic Arthritis Compound Library

All TRP Channel Isoforms

All GLUT Isoforms

All Cytochrome P450 Isoforms

All Interleukin Related Isoforms

All TNF Receptor Isoforms

Biological Activity

Chemical Information

Solvent & Solubility

Purity & Documentation

References

Help & FAQs

Complete Stock Solution Preparation Table

TRPV1 antagonist 10 Related Classifications

HY-172774 Related Classifications